BRINGING YOU INFORMATION.  PROVIDING YOU A PLATFORM.

 

 
THE PHARMA REVIEW (JULY - AUGUST 2012)

Clinical Trials Market Continues Growth Momentum, Bucking the Global Economy Slow Down

Prof O.R.S.Rao

Introduction:
 
Trends of R&D spend by Global Pharma companies
Despite global economy slow down, during 2011, large global pharma companies continued their spend on R&D, as they understand the long term value created by R&D. As can be seen from table-1, excepting for Merck and Pfizer, there was growth in R&D spend of each of the top 10 pharma companies, ranging from 2.8% to 14.2% . R&D spend, as % of sales revenue remained at the same level as 2010, at 15-16%. As can be seen from chart-1, about 38% of the R&D spend is towards Clinical Trials.

 

 

Go to Content Index Page

PHARMA REVIEW - ARTICLES ARCHIVE ( COMPLETE LIST)

 

The above content is an abstract only. For the full Article please contact:
KONGPOSH Publications Pvt. Ltd.
ICS House, C-19, Commercial Complex, SDA, Opp. IIT Gate, New Delhi, India -110016
Tel.: 26855839, 9811195411
Email: kongposhpub@gmail.com, Website: http://www.kppub.com

 
 
 
 

Copyright KONGPOSH PUBLICATIONS Pvt. Ltd.